The Scientist

» stem cell trials

Most Recent

image: CIRM Ups Translational Velocity

CIRM Ups Translational Velocity

By | December 21, 2015

California’s stem cell agency unveiled a 5-year plan that includes starting 50 new clinical trials.

0 Comments

image: Heart Strings

Heart Strings

By | May 1, 2015

An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients

0 Comments

image: Hearts on Trial

Hearts on Trial

By | May 1, 2015

As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.

2 Comments

image: Stem Cell Trial for Eye Disease Commences

Stem Cell Trial for Eye Disease Commences

By | September 12, 2014

Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.

0 Comments

image: Done with Immunosuppressants

Done with Immunosuppressants

By | July 3, 2014

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

2 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: More Evidence of Stem Cell Errors

More Evidence of Stem Cell Errors

By | February 25, 2014

A committee at the University of Düsseldorf finds misconduct in cardiologist Bodo-Eckehard Strauer’s work.  

0 Comments

image: Stem-Cell Clinic Moves to Mexico

Stem-Cell Clinic Moves to Mexico

By | February 1, 2013

A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.  

0 Comments

image: Opinion: Regenerating Safely

Opinion: Regenerating Safely

By | January 21, 2013

Patient safety is paramount in regulating new stem cell treatments.

1 Comment

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS